Harvard Bioscience (HBIO) Free Cash Flow Growth (5y) (2015 - 2026)
Harvard Bioscience (HBIO) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.41% |
| Dec 31, 2025 | -17.34% |
| Sep 30, 2025 | -3.22% |
| Jun 30, 2025 | 4.99% |
| Mar 31, 2025 | -1.22% |
| Dec 31, 2024 | -4.39% |
| Sep 30, 2024 | -21.19% |
| Jun 30, 2024 | -45.02% |
| Mar 31, 2024 | -16.50% |
| Dec 31, 2023 | 6.81% |
| Sep 30, 2023 | 34.80% |
| Jun 30, 2023 | 21.72% |
| Mar 31, 2023 | 106.21% |
| Dec 31, 2022 | 32.74% |
| Sep 30, 2022 | -35.75% |
| Jun 30, 2022 | -36.15% |
| Mar 31, 2022 | -24.91% |
| Dec 31, 2021 | -15.54% |
| Sep 30, 2021 | -20.48% |
| Jun 30, 2021 | -18.31% |